Published in Arthritis Rheum on January 01, 2012
Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) | NCT00065806
Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat Med (2012) 1.63
Unmet medical needs in systemic lupus erythematosus. Arthritis Res Ther (2012) 1.14
Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus. Annu Rev Med (2012) 1.13
Update on differences between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Res Ther (2013) 1.07
Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. Eur Heart J (2014) 1.04
A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus. Arthritis Rheumatol (2014) 1.02
Vitamin D deficiency is common and associated with increased C-reactive protein in children and young adults with lupus: an Atherosclerosis Prevention in Pediatric Lupus Erythematosus substudy. Lupus Sci Med (2014) 0.96
Vitamin D status is a determinant of atorvastatin effect on carotid intima medial thickening progression rate in children with lupus: an Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) substudy. Lupus Sci Med (2014) 0.96
Cardiovascular disease in lupus: insights and updates. Curr Opin Rheumatol (2013) 0.93
Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection. AIDS (2016) 0.90
Paediatric rheumatic disease: lessons from SLE: children are not little adults. Nat Rev Rheumatol (2012) 0.89
Cardiovascular risk in pediatric-onset rheumatological diseases. Arthritis Res Ther (2013) 0.88
Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives. Drugs (2016) 0.88
Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein. Ann Rheum Dis (2013) 0.86
Nonstatin Low-Density Lipoprotein-Lowering Therapy and Cardiovascular Risk Reduction-Statement From ATVB Council. Arterioscler Thromb Vasc Biol (2015) 0.83
Why are kids with lupus at an increased risk of cardiovascular disease? Pediatr Nephrol (2015) 0.78
Should children and adolescents with systemic lupus erythematosus be given statin therapy to prevent early atherosclerosis? Arthritis Rheum (2012) 0.77
Accelerated atherosclerosis in SLE: mechanisms and prevention approaches. Int J Clin Rheumtol (2012) 0.76
A clinically relevant benefit of statins in young patients with systemic lupus erythematosus cannot be excluded: comment on the article by Schanberg et al. Arthritis Rheum (2012) 0.75
Advances in the Care of Children with Lupus Nephritis. Pediatr Res (2016) 0.75
Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus. Lupus (2016) 0.75
Safety and Efficacy of Atorvastatin in Human Immunodeficiency Virus-infected Children, Adolescents and Young Adults With Hyperlipidemia. Pediatr Infect Dis J (2017) 0.75
Pediatric Statin Administration: Navigating a Frontier with Limited Data. J Pediatr Pharmacol Ther (2016) 0.75
Altered lipoproteins in patients with systemic lupus erythematosus are associated with augmented oxidative stress: a potential role in atherosclerosis. Arthritis Res Ther (2016) 0.75
Progression of noncalcified and calcified coronary plaque by CT angiography in SLE. Rheumatol Int (2016) 0.75
The Use of Primary Prevention Statin Therapy in Those Predisposed to Atherosclerosis. Curr Atheroscler Rep (2017) 0.75
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1997) 43.47
Adherence to medication. N Engl J Med (2005) 39.77
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet (2005) 32.41
Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med (1999) 16.30
Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation (2007) 11.95
The PedsQL: measurement model for the pediatric quality of life inventory. Med Care (1999) 11.09
Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med (2003) 7.86
Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation (1997) 7.03
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum (1996) 6.88
Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol (1997) 6.80
Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol (1997) 6.10
Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA (2007) 6.02
Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA (2004) 3.55
A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. Atherosclerosis (2003) 2.97
The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med (2005) 2.92
Carotid intima-media thickness measurements in intervention studies: design options, progression rates, and sample size considerations: a point of view. Stroke (2003) 2.61
American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation (2003) 2.51
Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study. Arthritis Rheum (2009) 2.26
Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum (1999) 2.21
Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum (2008) 2.06
Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2010) 1.84
Normative values for intima-media thickness and distensibility of large arteries in healthy adolescents. J Hypertens (2005) 1.70
Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors. Curr Control Trials Cardiovasc Med (2005) 1.63
A pravastatin dose-escalation study in systemic lupus erythematosus. Rheumatol Int (2007) 1.54
Statins for treatment of dyslipidemia in chronic kidney disease. Perit Dial Int (2006) 1.53
The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis. Atherosclerosis (2008) 1.52
Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus. Arthritis Rheum (2007) 1.43
Morbidity in systemic lupus erythematosus. J Rheumatol Suppl (1987) 1.41
Progression of carotid intima-media thickness and plaque in women with systemic lupus erythematosus. Arthritis Rheum (2008) 1.41
Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Arthritis Rheum (2009) 1.37
Intima-media thickness and diameter of carotid and femoral arteries in children, adolescents and adults from the Stanislas cohort: effect of age, sex, anthropometry and blood pressure. J Hypertens (1998) 1.29
Predictors of carotid atherosclerosis in systemic lupus erythematosus. J Rheumatol (2006) 1.01
Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin in subclinical atherosclerosis--the rationale and methodology of the METEOR study. Cardiovasc Drugs Ther (2004) 0.99
Assessment of atherosclerotic risk factors and endothelial function in children and young adults with pediatric-onset systemic lupus erythematosus. Arthritis Rheum (2004) 0.98
Nephrotic-range proteinuria, the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum (2000) 0.96
Sex differences of carotid intima-media thickness in healthy children and adolescents. Atherosclerosis (2009) 0.95
Barriers to a trial of atherosclerosis prevention in systemic lupus erythematosus. Arthritis Rheum (2005) 0.91
Effects of a 3-month course of rosuvastatin in patients with systemic lupus erythematosus. Ann Rheum Dis (2009) 0.90
Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study. Arthritis Rheum (2009) 0.88
Assessment of myocardial perfusion and function in childhood systemic lupus erythematosus. J Pediatr (1998) 0.88
An in vitro study of the effects of lovastatin on human fetal brain cells. Neurotoxicol Teratol (1995) 0.87
Therapy Insight: cardiovascular disease in pediatric systemic lupus erythematosus. Nat Clin Pract Rheumatol (2008) 0.84
Comment on: Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 week controlled trial. Rheumatology (Oxford) (2008) 0.84
Relation of arterial stiffness to left ventricular structure and function in adolescents and young adults with pediatric-onset systemic lupus erythematosus. J Rheumatol (2007) 0.83
Designs of RADIANCE 1 and 2: carotid ultrasound studies comparing the effects of torcetrapib/atorvastatin with atorvastatin alone on atherosclerosis. Curr Med Res Opin (2007) 0.83
Endothelial function analysis and atherosclerotic risk factors in adolescents with systemic lupus erythematosus. Int J Adolesc Med Health (2008) 0.82
The management of pediatric systemic lupus erythematosus. Nat Clin Pract Rheumatol (2005) 0.79
Structural identification of autoinducer of Photobacterium fischeri luciferase. Biochemistry (1981) 11.48
Structure of the autoinducer required for expression of Pseudomonas aeruginosa virulence genes. Proc Natl Acad Sci U S A (1994) 11.44
Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements. Cell (1988) 9.04
Geographical variation in mortality from conditions amenable to medical intervention in England and Wales. Lancet (1983) 6.66
Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia (2009) 6.55
Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell (1989) 6.11
Sclerodermalike esophageal disease in children breast-fed by mothers with silicone breast implants. JAMA (1994) 5.85
Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study. JAMA (1998) 5.80
Reducing frailty and falls in older persons: an investigation of Tai Chi and computerized balance training. Atlanta FICSIT Group. Frailty and Injuries: Cooperative Studies of Intervention Techniques. J Am Geriatr Soc (1996) 5.54
Inhibition and activation of bacterial luciferase synthesis. J Bacteriol (1972) 5.15
Enzymatic synthesis of a quorum-sensing autoinducer through use of defined substrates. Science (1996) 4.86
Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med (2000) 4.76
T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity (2001) 4.62
Structurally distinct bacterial luciferases. Biochemistry (1969) 4.03
A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST) N Engl J Med (1994) 3.73
Analogs of the autoinducer of bioluminescence in Vibrio fischeri. Arch Microbiol (1986) 3.67
The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity (2001) 3.52
Propensity of ectopic liver to hepatocarcinogenesis: case reports and a review of the literature. Hepatology (1999) 3.29
Induction of endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor, IRF-1. Nature (1989) 3.25
Evidence for a nuclear factor(s), IRF-1, mediating induction and silencing properties to human IFN-beta gene regulatory elements. EMBO J (1988) 3.11
Analogs of the autoinducer 3-oxooctanoyl-homoserine lactone strongly inhibit activity of the TraR protein of Agrobacterium tumefaciens. J Bacteriol (1998) 2.91
Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study. Stroke (1995) 2.86
Quorum sensing in Vibrio fischeri: probing autoinducer-LuxR interactions with autoinducer analogs. J Bacteriol (1996) 2.82
Radiologic determination of intravascular volume status using portable, digital chest radiography: a prospective investigation in 100 patients. Crit Care Med (2001) 2.78
Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. Stroke (1993) 2.74
The JAK2 V617F tyrosine kinase mutation in myelodysplastic syndromes (MDS) developing myelofibrosis indicates the myeloproliferative nature in a subset of MDS patients. Leukemia (2005) 2.71
Salt and pH-dependent changes of the purple membrane absorption spectrum. Photochem Photobiol (1984) 2.42
Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways. Proc Natl Acad Sci U S A (1989) 2.38
Expression of Period genes: rhythmic and nonrhythmic compartments of the suprachiasmatic nucleus pacemaker. J Neurosci (2001) 2.30
Cloning, sequence analysis, and expression of genes encoding xylan-degrading enzymes from the thermophile "Caldocellum saccharolyticum". Appl Environ Microbiol (1990) 2.22
Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatology (Oxford) (2005) 2.19
Rapid intravenous infusion of amphotericin B: a pilot study. Am J Med (1992) 2.18
Copper homeostasis in the mammalian system. Physiol Rev (1973) 2.16
Community care and criminal offending in schizophrenia. Lancet (2000) 2.13
Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis (1997) 2.11
Increased urinary NO3(-) + NO2- and neopterin excretion in children breast fed by mothers with silicone breast implants: evidence for macrophage activation. J Rheumatol (1996) 2.08
The structure of bacteriorhodopsin at 3.0 A resolution based on electron crystallography: implication of the charge distribution. J Mol Biol (1999) 2.07
Arterial stiffness: a new cardiovascular risk factor? Am J Epidemiol (1994) 2.02
Acceleration of academic progress through the manipulation of peer influence. Behav Res Ther (1968) 2.02
Visual acuity and contrast sensitivity in multiple sclerosis--hidden visual loss: an auxiliary diagnostic test. Brain (1977) 2.01
VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration. Cell Death Differ (2001) 2.00
Sex-specific associations of magnetic resonance imaging-derived intra-abdominal and subcutaneous fat areas with conventional anthropometric indices. The Atherosclerosis Risk in Communities Study. Am J Epidemiol (1996) 1.99
Involvement of a cis-element that binds an H2TF-1/NF kappa B like factor(s) in the virus-induced interferon-beta gene expression. Nucleic Acids Res (1989) 1.97
Sex differences in the solitary and assaultive fantasies of delinquent and nondelinquent adolescents. Adolescence (1996) 1.94
Inhibition by quinolones of DNA gyrase from Staphylococcus aureus. Antimicrob Agents Chemother (1991) 1.93
Knockout of the Sendai virus C gene eliminates the viral ability to prevent the interferon-alpha/beta-mediated responses. FEBS Lett (1999) 1.92
Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics (2000) 1.91
A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis. Oncogene (1997) 1.88
Evidence for motility-related fimbriae in the gliding microorganism Myxococcus xanthus. Can J Microbiol (1976) 1.85
Imatinib mesylate-induced hepato-toxicity in chronic myeloid leukemia demonstrated focal necrosis resembling acute viral hepatitis. Leukemia (2002) 1.85
Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1995) 1.84
Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma. Am J Gastroenterol (1999) 1.83
Evolution of the archaeal rhodopsins: evolution rate changes by gene duplication and functional differentiation. J Mol Biol (1999) 1.83
Sudden death in psychiatric patients. Br J Psychiatry (1998) 1.81
Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses. Proc Natl Acad Sci U S A (1996) 1.79
New-onset juvenile dermatomyositis: comparisons with a healthy cohort and children with juvenile rheumatoid arthritis. Arthritis Rheum (1997) 1.78
Role of urotensin II in patients on dialysis. Lancet (2001) 1.77
Ambient neighbourhood noise and children's mental health. Occup Environ Med (2002) 1.73
A single receptor encoded by vzg-1/lpA1/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid. Proc Natl Acad Sci U S A (1998) 1.73
Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: implications for the monoaminergic basis of impulsive behaviour. Psychopharmacology (Berl) (1999) 1.68
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011. Ann Rheum Dis (2012) 1.67
A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness. J Gen Virol (2001) 1.67
In vivo induction of apoptosis by influenza virus. J Gen Virol (1995) 1.65
The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects. West J Med (1990) 1.65
Nonoperative management of acute epidural hematoma diagnosed by CT: the neuroradiologist's role. AJNR Am J Neuroradiol (1992) 1.65
Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma. Eur J Surg Oncol (2002) 1.64
Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification. J Pediatr (1983) 1.64
Brain morphological changes and early marijuana use: a magnetic resonance and positron emission tomography study. J Addict Dis (2000) 1.63
Is the stroke belt disappearing? An analysis of racial, temporal, and age effects. Stroke (1995) 1.60
Catabolite repression of bacterial bioluminescence: functional implications. Proc Natl Acad Sci U S A (1972) 1.59
Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome. Obstet Gynecol (1997) 1.59
Circadian rhythmicity restored by neural transplant. Immunocytochemical characterization of the graft and its integration with the host brain. J Neurosci (1987) 1.58
The usefulness of a piezo-micromanipulator in intracytoplasmic sperm injection in humans. Hum Reprod (1999) 1.57
Clinical and immunological profiles of 25 patients with pemphigoid gestationis. Br J Dermatol (2014) 1.57
Differentiation of malignant to benign cells. Cancer Res (1971) 1.56
Dynamic structure of biological membranes as probed by 1,6-diphenyl-1,3,5-hexatriene: a nanosecond fluorescence depolarization study. Biochemistry (1981) 1.56
Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Arthritis Rheum (1997) 1.55
Existence of a proton transfer chain in bacteriorhodopsin: participation of Glu-194 in the release of protons to the extracellular surface. Biochemistry (1998) 1.55
Isolation of an antitumor compound from Agaricus blazei Murill and its mechanism of action. J Nutr (2001) 1.55
The carboxy-terminal region of mammalian HSP90 is required for its dimerization and function in vivo. Mol Cell Biol (1994) 1.54
Antiphospholipid antibodies and reproduction: the antiphospholipid antibody syndrome. Am J Reprod Immunol (1999) 1.54
Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study. J Intern Med (2009) 1.53
Age-dependent alterations in hepatic subcellular copper distribution and plasma ceruloplasmin. Am J Physiol (1970) 1.53
Dietary fat intake and carotid artery wall thickness: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol (1994) 1.53
Synthesis and damage specificity of a novel probe for the detection of abasic sites in DNA. Biochemistry (1993) 1.52
Chimerism in children with juvenile dermatomyositis. Lancet (2001) 1.52
Neuronal circuits are subdivided by differential expression of type-II classic cadherins in postnatal mouse brains. Mol Cell Neurosci (1997) 1.52
The outer membrane permeability-increasing action of deacylpolymyxins. J Antibiot (Tokyo) (1991) 1.52
Demonstration of the exact anatomic tachycardia circuit in the fast-slow form of atrioventricular nodal reentrant tachycardia. Circulation (2001) 1.51
The distribution of costs of care in mechanically ventilated patients with chronic obstructive pulmonary disease. Crit Care Med (2000) 1.51
Physiological, motivational, and cognitive effects of aircraft noise on children: moving from the laboratory to the field. Am Psychol (1980) 1.50
Current medication choices in juvenile rheumatoid arthritis II--update of a survey performed in 1993. J Clin Rheumatol (2001) 1.50
Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. J Diabetes Complications (2001) 1.49
Joint distribution at presentation in children with pauciarticular arthritis. J Pediatr (1999) 1.49
Right ventricular ejection fraction during exercise in patients with recent myocardial infarction: effect of the interventricular septum. Am Heart J (1994) 1.49
Results of endoscopic sinus surgery in pediatric patients with chronic sinusitis and asthma. Arch Otolaryngol Head Neck Surg (1994) 1.49
Beta-catenin expression in human cancers. Am J Pathol (1996) 1.47